Recalls / Active ingredient / Olanzapine
Olanzapine
4 FDA drug recalls involving the active ingredient “Olanzapine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-11-25 | Class II | Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeto | Macleods Pharmaceuticals Ltd |
| 2022-02-16 | Class II | Olanzapine Tablets, USP 10 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA , Inc. Plainsb | Macleods Pharma Usa Inc |
| 2021-06-29 | Class II | Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, L | Eli Lilly & Company |
| 2016-10-13 | Class III | Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Lim | Dr. Reddy's Laboratories, Inc. |